Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115088
Chunk: 170

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 170
---
 may be disadvantageous for a holder to do so; (ii) sell such SPAC Warrants at the then-current market price when a holder might otherwise wish to hold such SPAC Warrants; or (iii) accept the nominal redemption price that, at the time the outstanding SPAC Warrants are called for redemption, is likely to be substantially less than the market value of such Warrants.

In addition, we may redeem the SPAC Warrants (other than Private Warrants still held by the initial purchasers thereof) at any time after they become exercisable and prior to their expiration for a number of shares of our Common Stock determined based on the fair market value of our Common Stock. The value received upon exercise of the SPAC Warrants (1) may be less than the value the holders would have received if they had exercised their SPAC Warrants at a later time where the underlying share price is higher and (2) may not compensate the holders for the value of the SPAC Warrants.

The Selling Stockholder acquired or may acquire the securities covered by this prospectus at a price that is substantially below the current trading price of such securities and may therefore make substantial profits upon resales.

The Selling Stockholder can sell, under this prospectus, up to 6,685,714 shares of Common Stock representing approximately 49.7% of the shares of our Common Stock outstanding as of March 31, 2025, assuming the exercise of all outstanding Penny Warrants for which underlying shares are registered for resale hereunder, which consists of (i) up to 6,500,000 shares of Common Stock issuable upon the exercise of currently exercisable Penny Warrants held by Oramed at an exercise price of $0.01 per share and (ii) up to 185,714 shares of Common Stock previously issued to Oramed upon the exercise of the Penny Warrants for 185,714 shares of Common Stock at an exercise price of $0.01 per share. The Selling Stockholder will be able to sell such shares registered for resale hereunder for so long as the registration statement of which this prospectus forms a part is available for use and if applicable, upon exercise of the Penny Warrants.

The sale of all the securities being offered in this prospectus could result in a decline in the public trading price of our securities. Even if the current trading price of our Common Stock is at or significantly below the price at which the Resale Shares were issued, the Selling Stockholder may have an